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Fructose intake as a risk factor 
for kidney stone disease
M Asselman1 and CF Verkoelen1
Taylor and Curhan report that consumption of fructose is 
independently associated with an increased risk of incident kidney 
stones. What could be the mechanisms underlying the relation 
between fructose intake and stone risk? And how should we 
incorporate this finding into the dietary advice that we give to our 
patients to prevent kidney stone formation?
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Nephrolithiasis is considered a disease 
of affluence, as its prevalence and inci-
dence are among the highest in indus-
trialized parts of the world. About 80% 
of all kidney stones are composed of 
calcium oxalate, mixed or not mixed 
with calcium phosphate. About half 
of the people with a first stone episode 
will form stones again within 10 years; 
this is influenced by lifestyle, including 
dietary habits.1–3
Taylor and Curhan4 (this issue) exam-
ined the possible relationship between 
fructose consumption and nephrolithi-
asis in a prospective study using die-
tary questionnaires completed by large 
cohorts. The use of high-fructose corn 
syrup has increased enormously during 
the past 30 years in the United States, 
hand in hand with an increase in the 
incidence of nephrolithiasis.5 Dietary 
total fructose intake is equal to the 
intake of free fructose (fructose con-
sumed as a monosaccharide) plus half 
the intake of sucrose (a disaccharide 
that is hydrolyzed to glucose and fruc-
tose). The main dietary sources of fruc-
tose in the study by Taylor and Curhan4 
were sugar-sweetened soft drinks, fruit 
juices, and fruits. The intake of fruc-
tose was independently associated with 
an increased risk of incident kidney 
stones. The question is how we should 
incorporate this finding into the die-
tary advice that we give to prevent new 
stone formation. In other words, should 
we advise our patients not to consume 
fruit and soft drinks? Remarkably, one 
of the conclusions during the recent 5th 
eULIS Symposium 2007 (12th European 
Symposium on Urolithiasis) in Lisbon 
was diametrically different in that 
fruit consumption was recommended 
as a reasonable alternative to potas-
sium citrate, one of the most effective 
drugs against stone formation. In their 
conclusions, Taylor and Curhan4 pro-
pose that clinicians caring for patients 
with stone disease should beware that 
a decreased consumption of dietary 
risk components, such as salt and ani-
mal protein, is not compensated by an 
increased intake of other risk factors, 
such as fructose.
The main dietary sources of citrate 
are citrus-based juices such as orange 
juice, grapefruit juice, and lemonade. 
Lemon juice (that is, pure lemon juice 
derived from lemons) contains nearly 
five times the concentration of citric 
acid that orange juice contains and 
seems to be the most efficient dietary 
alternative to potassium citrate.6,7 Tay-
lor and Curhan4 describe that orange 
juice—rich in citrate—accounted for a 
substantial amount of both free fruc-
tose and sucrose intake. Lemonade 
usually contains lemon juice—rich in 
citrate—water, and a sweetener such as 
high-fructose corn syrup. The study by 
Taylor and Curhan4 therefore seems to 
make dietary advice to stone formers 
more complex and raises new ques-
tions about the effects of consumption 
of fruits and fruit juices rich in both 
citrate and fructose.
What could be the mechanism by 
which fructose consumption increases 
the risk of stone formation? Kidney 
stones are composed of crystals that 
are formed in anyone’s kidneys. Stone 
formers differ from non-stone form-
ers in that they retain and accumulate 
these crystals in their kidneys.8 Crystal 
retention depends on sites of fixation in 
the kidney, including the tubules (tubu-
lar nephrocalcinosis), the interstitium 
(interstitial nephrocalcinosis), and the 
calyces (kidney stones) (Figure 1).9,10 
The composition of the urine is highly 
influenced by dietary habits. The ulti-
mate solute concentrations, however, 
are determined by the amount of water 
that is reabsorbed in the distal tubules 
and collecting ducts. Depending on 
the body’s need for water conservation, 
water is extracted into the renal medul-
lary interstitium under the influence of 
antidiuretic hormone. The occasional 
precipitation of poorly soluble waste 
salts is unavoidable during urinary 
concentration despite the presence of 
crystallization inhibitors such as citrate 
and glycoproteins.11 All stone formers 
are advised to increase their daily fluid 
intake to dilute their urine. To avoid 
risk conditions such as high urine cal-
cium (hypercalciuria) and low urine 
citrate (hypocitraturia), many stone 
formers are also advised to limit their 
daily consumption of sodium chloride 
and animal protein.12,13 Taylor and 
Curhan4 expect that fructose affects 
urinary supersaturation. In their dis-
cussion they describe that high dietary 
fructose and low magnesium leads to 
nephrocalcinosis in rats and hyper-
calciuria in healthy men, but this was 
not supported by their own findings. 
The literature reported a relationship 
between fructose consumption and 
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oxalate excretion, especially in combi-
nation with a low vitamin B6 intake, but 
this relationship also was not confirmed 
by their own data. Although fructose 
intake may lead to increased uric acid 
excretion (hyperuricosuria), Curhan 
and colleagues previously reported that 
there is no link between uric acid excre-
tion and the risk of stone formation.14 
Taken together, there is only limited 
support for the concept that the con-
sumption of fructose influences the 
levels of supersaturation in the urine.
As is mentioned above, nephrolithiasis 
does not depend only on the produc-
tion of concentrated urine. Kidney 
stone formation should be considered 
a two-step process involving crystal for-
mation and retention.9,10 As we do not 
know exactly how crystals are retained 
in the kidney, most treatment strate-
gies logically aim at lowering the levels 
of supersaturation in the urine. In our 
opinion, these measures may slow down 
the stone-forming process, but a true 
cure depends on methods preventing 
crystal retention. The report that rats 
fed a magnesium-deficient, fructose-
rich diet had significantly higher levels 
of nephrocalcinosis seems particularly 
intriguing,15 because this opens the 
possibility that the intake of fructose 
influences crystal retention. Crystal 
retention and accumulation occurs in 
the tubules (tubular nephrocalcinosis), 
the interstitium (interstitial nephro-
calcinosis), and the calyces (kidney 
stones) (Figure 1).9 It is possible that 
these different manifestations of renal 
stone disease are interrelated. Hopefully 
future studies will reveal whether and 
how the consumption of fructose influ-
ences the various aspects of the patho-
physiology of renal stone disease.
Finally, food-frequency question-
naires are useful tools for identifying 
diet–disease associations in large pop-
ulations. However, it is questionable 
whether they provide assessments of 
daily nutrient intakes accurate enough to 
identify biochemical and physiological 
changes that may occur. Studies using 
diets where nutrient intakes are accu-
rately controlled are required. We look 
forward to such studies where the con-
tent of fructose in the diet is varied and 
the resulting changes in metabolism and 
urinary excretions are identiﬁed.
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Figure 1 | Kidney anatomy and the localization of the different manifestations of renal stone disease.
